Last reviewed · How we verify
Theophyllin
At a glance
| Generic name | Theophyllin |
|---|---|
| Sponsor | University of Bergen |
| Target | Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1 |
| Modality | Small molecule |
| Therapeutic area | Respiratory |
| Phase | FDA-approved |
Approved indications
- Acute exacerbation of asthma
- Asthma
- Asthma management
- Asthma night-time symptoms
- Asthma-chronic obstructive pulmonary disease overlap syndrome
- Bronchitis
- Bronchospasm
- COPD Associated with Chronic Bronchitis
- Chronic Obstructive Pulmonary Disease with Bronchospasms
- Disorder of lung
- Pulmonary emphysema
Common side effects
- Nausea
- Vomiting
- Headache
- Insomnia
- Diarrhea
- Irritability
- Restlessness
- Fine skeletal muscle tremors
- Transient diuresis
Serious adverse events
- Cardiac arrhythmias
- Intractable seizures
- Persistent vomiting
- Multifocal atrial tachycardia
- Atrial flutter
- Seizures
Key clinical trials
- Effectiveness of Xuanfei Jiangzhuo Decoction for Influenza-Induced AECOPD
- Theophylline for Treatment of Pseudohypoparathyroidism (PHASE2)
- Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old (PHASE2)
- Theophylline Treatment for Pseudohypoparathyroidism (PHASE2)
- Diuretic Effect of Aminophylline and Furosemide in Adult Patients Undergoing Cardiac Surgical Procedures (NA)
- Reverse Triple Negative Immune Resistant Breast Cancer (PHASE2)
- Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data (PHASE3)
- Prevention of Cisplatin-induced Nephrotoxicity (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Theophyllin CI brief — competitive landscape report
- Theophyllin updates RSS · CI watch RSS
- University of Bergen portfolio CI